SCHEMBL6427166

SCHEMBL6427166

O=C1C(c2ccc([N+](=O)[O-])cc2)=C(C(F)(F)F)C(=O)N1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.47
CASP3 P42574 1/20 0.47
CASP4 P49662 1/20 0.47
CASP7 P55210 1/20 0.47
CASP9 P55211 1/20 0.47
CASP6 P55212 1/20 0.47
CASP8 Q14790 1/20 0.47
MAPT P10636 5/20 0.46
APP P05067 4/20 0.46
SNCA P37840 4/20 0.46
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TLR9 Q9NR96 1/20 0.44
AR P10275 4/20 0.44
NR1H2 P55055 2/20 0.43
NR1H3 Q13133 2/20 0.43
CFTR P13569 1/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6428548 0.83 NR1H2 (0.56) CASP3MAPTALDH1A1MEN1KMT2A
SCHEMBL6427989 0.82 CASP1 (0.51) CASP1CASP3CASP4CASP7CASP9
SCHEMBL6429024 0.81 PTGS2 (0.46) NR1H2NR1H3
SCHEMBL6426783 0.80 NR1H2 (0.47) CASP3MAPTALDH1A1MEN1KMT2A
SCHEMBL6427122 0.76 NR1H2 (0.47) MAPTALDH1A1MEN1KMT2ANR1H2
SCHEMBL6427487 0.74 DHPS (0.46) ALDH1A1NR1H2NR1H3LMNACYP2C19
SCHEMBL6429398 0.72 NPSR1 (0.41) CASP3MAPTALDH1A1MEN1KMT2A
SCHEMBL6426786 0.72 MAPT (0.46) CASP3MAPTALDH1A1KMT2ANR1H2
SCHEMBL1832812 0.71 CA12 (0.60) CASP1CASP3CASP4CASP7CASP9
SCHEMBL6429546 0.71 OPRK1 (0.40) CASP3ALDH1A1MEN1KMT2ANR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005024755-A2 MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS OR DIABETES DECIPHERA PHARMACEUTICALS, LLC. (US) 2005-03-17 WO disclosed